DIA EuroMeeting

Start Date 25/03/2014 End Date 27/03/2014

From 25 to 27 March 2014, IMI participated in the Drug Information Association (DIA) EuroMeeting that took place at the Austrian Centre Vienna in Vienna, Austria.


Event exhibition

IMI was present at the exhibition of this event with an exhibition standIMI's project on the European Medicines Research Training Network (EMTRAIN) also participated in the DIA exhbition.


Conference programme

IMI and its projects EUPATI (European Patients' Academy on Therapeutic Innovation), SAFE-T (Safer and Faster Evidence-based Translation) and GetReal (Incorporating real-life clinical data into drug development) were also represented in the conference programme through the following sessions:  

  • Session 0901: 'Patients as partners in clinical research'
    Wednesday 26 March, 09:00 - 10:30 
    Session Chair: Jan Geissler, IMI EUPATI project and Leukemia Patient Advocates Foundation
  • Session 1402: 'Innovation through public-private partnership collaborations' 
    Wednesday, 26 March11:00 - 12:30
    Session Chair: Salah-Dine Chibout, Global Head Discovery & Investigative Safety, Novartis Pharma, Switzerland, Member of the IMI Governing board
    Presentation: 'IMI as a European Flagship to Address Major Health Challenges' by Michel Goldman, Executive Director of IMI 
    Presentation: 'Biomarker Qualification for Drug-Induced Injury to Kidney, Liver and the Vascular System within IMI SAFE-T Projectby Thomas Joos, Deputy Managing Director, NMI Natural and Medical Sciences Institute at the University of Tübingen, Germany
  • Session 1404: Innovation in clinical trials design and evaluation
    Wednesday, 26 March, 16:00-17:30
    'Real-Life Data in Drug Development: Perspectives on R&D, market authorisation and HTA (IMI GetReal)' by Diederick GrobbeeJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht


About the DIA EuroMeeting

This event was DIA's 26th annual EuroMeeting. This year's theme was ‘Different perspectives – one vision: Better healthcare for patients’. This event focused on putting patients' rights in the centre of discussions and broadly encouraged patients' contribution to all sessions. The DIA EuroMeeting offered a special opportunity to actively listen to perspectives of a diverse and wide group of stakeholders

The broad and inclusive debate promoted by this event generated better understanding of stakeholders' needs and promoted innovation in healthcare.

The DIA EuroMeeting programme can be downloaded from the event website.